J.G.P. Pires

567 total citations
46 papers, 470 citations indexed

About

J.G.P. Pires is a scholar working on Cellular and Molecular Neuroscience, Molecular Biology and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, J.G.P. Pires has authored 46 papers receiving a total of 470 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Cellular and Molecular Neuroscience, 12 papers in Molecular Biology and 11 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in J.G.P. Pires's work include Receptor Mechanisms and Signaling (10 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Heart Rate Variability and Autonomic Control (9 papers). J.G.P. Pires is often cited by papers focused on Receptor Mechanisms and Signaling (10 papers), Neurotransmitter Receptor Influence on Behavior (9 papers) and Heart Rate Variability and Autonomic Control (9 papers). J.G.P. Pires collaborates with scholars based in Brazil, United Kingdom and Mexico. J.G.P. Pires's co-authors include Andrew G. Ramage, G.R. Abreu, Margareth Ribeiro Moysés, Nazaré Souza Bissoli, Richard Bogle, Washington Luiz Silva Gonçalves, Sônia Alves Gouvêa, Luciana Carletti, Antônio M. Cabral and Regina Maria Papais Alvarenga and has published in prestigious journals such as Brain Research, British Journal of Pharmacology and European Journal of Pharmacology.

In The Last Decade

J.G.P. Pires

44 papers receiving 444 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J.G.P. Pires Brazil 15 137 101 93 91 88 46 470
Masashi Okuro Japan 15 47 0.3× 126 1.2× 202 2.2× 110 1.2× 72 0.8× 52 727
Ulaş Mehmet Çamsarı United States 15 84 0.6× 23 0.2× 37 0.4× 118 1.3× 77 0.9× 26 597
Fatemeh Moradi Iran 13 96 0.7× 17 0.2× 43 0.5× 86 0.9× 78 0.9× 30 552
Sarah Phillips Australia 14 51 0.4× 101 1.0× 39 0.4× 121 1.3× 116 1.3× 33 610
Marialuisa Perrotta Italy 12 73 0.5× 141 1.4× 19 0.2× 75 0.8× 111 1.3× 22 613
Sally I. Sharp United Kingdom 15 111 0.8× 58 0.6× 13 0.1× 127 1.4× 129 1.5× 26 753
Kathleen Watson United States 10 37 0.3× 42 0.4× 32 0.3× 140 1.5× 100 1.1× 29 489
Jóhann Axelsson Iceland 8 64 0.5× 58 0.6× 81 0.9× 97 1.1× 125 1.4× 12 378
In‐Sun Choi South Korea 12 102 0.7× 89 0.9× 47 0.5× 32 0.4× 58 0.7× 26 359
Howard A. Gross United States 12 67 0.5× 103 1.0× 106 1.1× 205 2.3× 75 0.9× 15 917

Countries citing papers authored by J.G.P. Pires

Since Specialization
Citations

This map shows the geographic impact of J.G.P. Pires's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J.G.P. Pires with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J.G.P. Pires more than expected).

Fields of papers citing papers by J.G.P. Pires

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J.G.P. Pires. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J.G.P. Pires. The network helps show where J.G.P. Pires may publish in the future.

Co-authorship network of co-authors of J.G.P. Pires

This figure shows the co-authorship network connecting the top 25 collaborators of J.G.P. Pires. A scholar is included among the top collaborators of J.G.P. Pires based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J.G.P. Pires. J.G.P. Pires is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pires, J.G.P., et al.. (2025). Metals, cardiovascular risk, and the interplay with oxidative stress: a mini-review. Brazilian Journal of Medical and Biological Research. 58. e14466–e14466.
2.
Pires, J.G.P., et al.. (2021). Manejo farmacológico da parada cardiorrespiratória em adultos / Pharmacological management of cardiorespiratory arrest in adults. Brazilian Journal of Health Review. 4(5). 20406–20425. 1 indexed citations
3.
Cabral, Antônio M., et al.. (2019). Impairment of natriuresis and diuresis induced by intrarenal adrenoceptor mechanisms in an experimental model of cirrhosis in rats. Heliyon. 5(12). e03066–e03066. 1 indexed citations
4.
5.
Gouvêa, Sônia Alves, Washington Luiz Silva Gonçalves, Margareth Ribeiro Moysés, et al.. (2011). Raloxifene Reduces Blood Pressure in Hypertensive Animals after Ovarian Hormone Deprivation. Basic & Clinical Pharmacology & Toxicology. 109(5). 334–338. 5 indexed citations
6.
Pires, J.G.P., et al.. (2009). Cardiovascular risk factors, their associations and presence of metabolic syndrome in adolescents. Jornal de Pediatria. 85(1). 55–60. 39 indexed citations
7.
Moysés, Margareth Ribeiro, et al.. (2006). Cardiovascular risk factors in a population of Brazilian schoolchildren. Brazilian Journal of Medical and Biological Research. 39(12). 1637–42. 19 indexed citations
8.
Cabral, Antônio M., et al.. (2005). Chronic treatment with mianserin prevents DOCA–salt hypertension in rats—evidence for the involvement of central 5-HT2 receptors. European Journal of Pharmacology. 518(2-3). 152–157. 3 indexed citations
9.
Pires, J.G.P., et al.. (2005). Acute effects of selective serotonin reuptake inhibitors on neuroleptic-induced catalepsy in mice. Brazilian Journal of Medical and Biological Research. 38(12). 1867–1872. 35 indexed citations
10.
Gouvêa, Sônia Alves, et al.. (2004). Activity of Angiotensin‐Converting Enzyme After Treatment with L‐Arginine in Renovascular Hypertension. Clinical and Experimental Hypertension. 26(6). 569–579. 12 indexed citations
11.
Pires, J.G.P., et al.. (2001). Cardiovascular and respiratory responses to microinjection of L-glutamate into the caudal pressor area in conscious and anesthetized rats. Brazilian Journal of Medical and Biological Research. 34(12). 1603–1606. 10 indexed citations
12.
13.
Pires, J.G.P., et al.. (1995). Effects of 5-HT3 receptor antagonists on neuroleptic-induced catalepsy in mice. Neuropharmacology. 34(1). 97–99. 33 indexed citations
14.
Pires, J.G.P., et al.. (1993). Effects of the 5-HT receptor antagonists cyanopindolol, ICI 169,369, cisapride and granisetron on neuroleptic-induced catalepsy in mice.. PubMed. 26(8). 847–52. 9 indexed citations
15.
Pires, J.G.P., Andrew G. Ramage, & Michael Jacobs. (1993). ICI 169,369, A 5‐HT2/5‐HT1C antagonist, that can evoke endothelium‐dependent relaxation in rabbit aorta. Journal of Autonomic Pharmacology. 13(4). 249–255. 2 indexed citations
16.
17.
Pires, J.G.P. & Fausto Edmundo Lima Pereira. (1991). Absence of hypersensitivity to the negative chronotropic effect of acetylcholine in the atria of mice acutely infected with Trypanosoma cruzi, cl strain. Revista da Sociedade Brasileira de Medicina Tropical. 24(4). 259–261. 1 indexed citations
18.
Pires, J.G.P. & Andrew G. Ramage. (1990). Evidence suggesting that the 5–HT2 antagonist ICI 169, 369 activates vagal afferents and in addition has a central hypotensive action in anaesthetized rats. Journal of Autonomic Pharmacology. 10(6). 345–352. 5 indexed citations
19.
Bogle, Richard, J.G.P. Pires, & Andrew G. Ramage. (1990). Evidence that central 5‐HT1A‐receptors play a role in the von Bezold‐Jarisch reflex in the rat. British Journal of Pharmacology. 100(4). 757–760. 32 indexed citations
20.
Pires, J.G.P., et al.. (1990). Inhibition of chlorpromazine-induced catalepsy by the 5-HT-1A ligands pindolol and buspirone in mice.. PubMed. 23(9). 869–71. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Masashi Okuro Breakdown of academic impact, for papers by Ulaş Mehmet Çamsarı Breakdown of academic impact, for papers by Fatemeh Moradi Breakdown of academic impact, for papers by Sarah Phillips Breakdown of academic impact, for papers by Marialuisa Perrotta Breakdown of academic impact, for papers by Sally I. Sharp Breakdown of academic impact, for papers by Kathleen Watson Breakdown of academic impact, for papers by Jóhann Axelsson Breakdown of academic impact, for papers by In‐Sun Choi Breakdown of academic impact, for papers by Howard A. Gross
Rankless by CCL
2026